On Thursday, Uganda confirmed an outbreak of the Ebola virus in its capital city Kampala, with the first confirmed patient dying from it a day before. As per the new developments, the officials are now preparing to deploy a trial vaccine to put an end to this outbreak.

Groups of scientists are working on the vaccine and deployment of more than 2,000 doses of a candidate vaccine against the Sudan strain of Ebola has been planned and confirmed by the Uganda Virus Research Institute. As per the World Health Organization (WHO), Uganda has access to 2,169 doses of trial vaccine. For now, however, there are no approved vaccines for the strain and officials are still investigating the source of the outbreak.

The WHO had also allocated $1 million from its contingency fund for emergencies to support quick action and contain the outbreak in the country.

Confirmed Case

On Wednesday, the Sudan strain of Ebola killed a nurse employed at Kampala's main referral hospital. It is after his death that Ebola was declared an outbreak in the country. Post-mortem samples too have confirmed the Sudan Ebola Virus Disease and at least 44 contacts of the deceased man have been listed for tracing. 30 of these are health workers.

Ebola is a highly infectious hemorrhagic fever, which is transmitted through contact with bodily fluids and tissue. Symptoms include headache, vomiting of blood, muscle pains and bleeding.

it was in the late 2022, when Uganda had last suffered an Ebola outbreak. It killed 55 of the 143 people who were infected and was declared over on January 11, 2023.

What Is Ebola Virus Disease?

As per the WHO, Ebola virus disease (EVD) is a rare but severe illness in humans and is often fatal. People can get infected with the virus if they touch an infected animal when preparing food, or touch body fluids of an infected person such as saliva, urine, faeces or semen, or things that have body fluids of an infected person like clothes or sheets.

How Does Transmission Work?

Ebola enters the body through cuts in the skin or when one is touching their eyes, nose or mouth. Early symptoms include fever, fatigue and headache.

It was first discovered in 1976 in two simultaneous outbreak, when in Nzara, South Sudan and other in Yambuku, Democratic Republic of Congo. The latter occurred near a village near the Ebola River, which is where it gets its name from.

It is highly infectious and transmissible disease, in fact, there have been cases of health-care workers who have frequently been infected while treating patients with suspected or confirmed Ebola. This occurs through close contact with patients when infection control precautions are not practiced strictly.

Cases of people conducted burial ceremonies, involving direct contact with the body of the deceased too can lead to the transmission of Ebola. Even after the long suffering and recovery, there is a possibility of sexual transmission. Pregnant women who get acute Ebola and recover may still carry the virus in their breastmilk, or in pregnancy related fluids and tissues.

Symptoms:

• feeling tired
• headache
• muscle and joint pain
• eye pain and vision problems
• weight gain
• belly pain and loss of appetite
• hair loss and skin problems
• trouble sleeping
• memory loss
• hearing loss
• depression and anxiety

Amid rising obesity, early diabetes risk, and mental health issues among children, India has expanded its child health screening program to include behavioral disorders and non-communicable disease (NCD) risk factors.

The Ministry of Health and Family Welfare rolled out the screening measures under the revised Rashtriya Bal Swasthya Karyakram (RBSK) 2.0 guidelines.

The guidelines include steps to address mental health conditions and early risk factors for diseases such as diabetes and hypertension. These were released at the recently concluded National Summit on Good Practices and Innovations in Public Healthcare Service Delivery.

The screening services are free and will be delivered through mobile health teams at Anganwadi centers and schools, ensuring universal outreach and early identification.

What Does The RBSK 2.0 Guideline Include?

• The guidance document establishes, for the first time, a structured and standardized national framework for the screening, diagnosis, treatment, and long-term management of childhood diabetes. It calls for universal screening of all children from birth to 18 years.

• Suspected cases will undergo immediate blood glucose testing and timely referral to district-level health facilities for confirmatory diagnosis and treatment.

• A free-of-cost care package will be available at public health facilities. This includes screening, diagnostic services, lifelong insulin therapy, monitoring devices such as glucometers and test strips, and regular follow-up care. This will reduce the financial burden and ensure uninterrupted treatment for children diagnosed with diabetes.

• The initiative promotes the “4Ts” awareness framework—Toilet, Thirsty, Tired, and Thinner—enabling parents, teachers, and caregivers to recognize early warning signs of Type 1 diabetes.

• The document also emphasizes the need to provide structured training on insulin administration, blood glucose monitoring, emergency response, and daily disease management. It outlines evidence-based treatment guidelines, regular monitoring schedules, and protocols for preventing complications.

• RBSK 2.0 introduces digital health cards, real-time data systems, and integrated platforms for tracking, monitoring, and service delivery. These digital innovations are expected to enhance program efficiency, accountability, and evidence-based decision-making across all levels of implementation.

Signs Of Diabetes In Children

Children with Type 1 Diabetes Mellitus can develop diabetic ketoacidosis (DKA) if it is not diagnosed on time, since they are insulin-dependent.

Dr. Archana Arya, Senior Consultant Pediatric & Adolescent Endocrinologist at the Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, told HealthandMe that DKA requires hospitalization for treatment, and if undiagnosed, it can lead to coma and death. Early diagnosis reduces morbidity and hospital admissions.

These children present with typical symptoms such as

• increased thirst,
• frequent urination,
• weight loss.

Type 2 Diabetes Mellitus may or may not present with typical symptoms, and children may develop long-term complications such as retinopathy and nephropathy if the condition goes undiagnosed for a prolonged period.

All overweight and obese children, especially those with a family history of Type 2 diabetes, those with acanthosis nigricans (thickened and dark skin behind the neck and underarms), and girls with PCOS are at high risk of developing Type 2 diabetes and should be screened annually to prevent complications.

The expert added that children with diabetes are at a higher risk of depression (2–3 times higher prevalence), anxiety, and suicidal ideation (in 8–27 percent of youth) due to dietary restrictions and the burden of multiple insulin injections in Type 1 diabetes. Diabetic youth are 1.7 times more likely to attempt suicide, often through insulin overdose.

Why Is The Initiative Important?

Dr. Seema Dhir, Unit Head & Senior Consultant, Internal Medicine, Artemis Hospitals, told HealthandMe that good health in early life is essential for preventing non-communicable diseases such as obesity, diabetes, and heart disease. Diabetes is often linked to poor lifestyle and health choices.

Early monitoring, detection, and effective management can reduce the growing burden of diabetes.

Dr. Munia Bhattacharya, Senior Consultant – Clinical Psychology, Mental Health and Behavioural Sciences, Marengo Asia Hospitals, Gurugram, emphasized that preventing non-communicable diseases like diabetes, heart disease, and obesity begins with maintaining both mental and physical well-being.

Providing mental support to children helps them cope better with stress and reduces the risk of anxiety, depression, and suicidal thoughts.

Children who are encouraged to express their feelings and seek help are less likely to experience anxiety, depression, and suicidal tendencies. Early awareness also builds coping skills, decision-making abilities, and healthier lifestyles—paving the way for long-term well-being and a more balanced, confident future.

Cancer treatment is often viewed as months of painful chemotherapy, radiotherapy, and surgeries that one might physically recover from but may continue to struggle with the trauma of for years. But now, thanks to a new injectable drug, cancer treatment may speed up for thousands of NHS patients in the UK. Pembrolizumab, also known as Keytruda, is that one-minute cancer drug injection that will likely speed up cancer treatment for thousands of patients—and soon, it will be available as a quicker jab instead of a half-hour drug.

What is pembrolizumab?

Pembrolizumab is an injectable drug prescribed to over 14,000 people in Britain every year. It works by stimulating the immune system to attack cancer cells on its own. Patients usually spend about two hours at a clinic when it is slowly administered for 30 minutes or more via a drip or IV line. However, this one-minute jab is now available in an injectable form and can be administered every three weeks or as a two-minute injection every six weeks.

The drug has now been made more concentrated, with an extra component added to help the body absorb it faster. This shot is given in the stomach or the thigh instead of being infused through a vein in the arm. Doctors say that this rapid jab, which takes less than a minute to deliver, can help patients get back to their lives without having to spend hours in a hospital chair; for a cancer patient, regular hospital trips and multiple rounds of therapy can be physically exhausting and mentally draining.

How will pembrolizumab benefit cancer patients?

Pembrolizumab, according to doctors, will make cancer therapy and treatment more convenient for patients, and it can also bring down waiting times. It is one of the most successful cancer drugs and has been celebrated as a game-changer in treating several tumour types. The NHS uses the drug to treat 14 types of cancer, such as lung, breast, bowel, womb, stomach, head and neck, and melanoma.

The first-ever patient to receive pembrolizumab was Shirley Xerxes, 89, from St Albans, Hertfordshire, who was suffering from bowel cancer. She spoke several times about how it changed her will to live and how little time it took.

How does pembrolizumab work?

Pembrolizumab tells the immune system to recognise and kill cancer cells. It can fight head and neck, lung, breast, and cervical cancer. The drug is administered every three weeks as a one-minute injection, or it is given every six weeks as a two-minute injection, depending on the cancer type.

The World Health Organization (WHO) said on May 3 that three people who died aboard a cruise ship in the Atlantic Ocean were suspected to have been infected with hantavirus. The rodent-borne virus can cause severe and sometimes fatal respiratory illness.

"To date, one case of hantavirus infection has been laboratory confirmed, and there are five additional suspected cases," the organization said in a post on social media platform X.

"Of the six affected individuals, three have died, and one is currently in intensive care in South Africa," it added.

In a statement provided to USA TODAY, Netherlands-based expedition cruise operator Oceanwide Expeditions said it was addressing a "serious medical situation" on board m/v Hondius. The ship was en route from Argentina to Cape Verde, an island nation off Africa's west coast.

What Is Hantavirus?

According to the Centers for Disease Control and Prevention (CDC), hantaviruses are a family of viruses that can cause severe illnesses and even death. The hantavirus is primarily spread by rodents through

• exposure to their urine,
• droppings,
• saliva,
• less commonly through a scratch or bite.

The CDC notes that hantaviruses are capable of causing diseases like hantavirus pulmonary syndrome or HPS and hemorrhagic fever with renal syndrome or HERS.

It can infect and cause serious diseases in people. It has mainly two syndromes. One is found in the Western Hemisphere, including in the US, which can cause HPS.

The most common hantavirus that causes HPS in the US is spread by the deer mouse. HERS is a group that is similar to illnesses caused by hantaviruses and is found mostly in Asia and Europe. There's another type, called the Seoul virus, which is a type of hantavirus that causes HERS and is found worldwide, including in the US.

The WHO did not specify the type of hantavirus or syndrome in the cruise incident, but did mention respiratory risks.

Hantavirus: What Are The Common Symptoms?

According to the CDC, symptoms can appear one to eight weeks after exposure, initially presenting fatigue, fever, and muscle aches. As the disease progresses, it can cause coughing, shortness of breath, and chest tightness as fluid accumulates in the lungs.

The CDC reports that about one-third of individuals who develop respiratory symptoms from the disease may not survive.

Despite extensive research, many questions remain unanswered, including why some cases are mild while others become severe and how antibodies develop. She and other researchers have been tracking patients over extended periods, hoping to uncover potential treatments.

Also read: India Concerned Over Measles Outbreak, Action Underway: Dr N K Arora| Exclusive

Hantavirus: How Can You Reduce Your Risk?

You can reduce your risk by eliminating and minimizing your contact with rodents in your home, workplace, or campsite. The best way is to seal holes and gaps in your home or garage and keep the rodents from entering your home. You can also place traps in and around your home to decrease rodent infestation. Clean up any easy-to-get food that could attract rodents.

Hantavirus: How Does The Diagnosis Work?

CDC notes that the diagnosis in a person who has been infected for less than 72 hours is difficult. If the initial test is done before the virus can be found, then a repeat test is required after 72 hours whenever the symptoms start to show up. Early symptoms, as mentioned above, like fever, headache, muscle aches, nausea, and fatigue, could also be easily confused with influenza, thus a test is extremely important.